Professor Thomas Eschenhagen, MD, studied Medicine at Hannover, trained for 3 years in Cardiology and 5 years in Experimental and Clinical Pharmacology at the University of Hamburg, where he completed a postgraduate study of Molecular Biology in 1992. He served as Director of Clinical Pharmacology at the University of Erlangen (1998-2002) and, since 2002, is Director of the Department of Experimental Pharmacology and Toxicology at the University of Hamburg. Since 2011, he serves as Speaker of the German Centre for Cardiovascular Research, DZHK. He is member of the German Academy of Science Leopoldina (2008) and President of the International Society for Heart Research (2019-2022). He published >280 full papers and >30 reviews or chapters in leading textbooks (>13,500 citations, H index 63). His research aims at a better understanding of cardiomyopathies and translating into the practice the promises of pluripotent stem cells by tissue engineering, a technology he pioneered in 1994.
